| CASP9 |
CASP9, MCH6: Caspase-9 precursor |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.132 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
1.132 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
1.132 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
1.132 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.132 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
| TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
1.132 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
1.132 |
Evidence |
|
| EPO |
EPO: Erythropoietin precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
1.132 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
O
|
| HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
1.132 |
Evidence |
|